Delivery Order SPE2DB24D3015-SPE2DB25FFYYX
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,028.75 firm fixed price delivery order contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,816.06 firm-fixed-price delivery order is for Otezla 30 mg tablets, a specialty medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,797.21 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,957.45 delivery order contract is for the supply of OTEZLA 30 MG TABLET 60S, a medication, and has a firm fixed price. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,467.36 firm-fixed-price delivery order is for the supply of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 15, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,909.70 firm-fixed-price delivery order is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $9,238.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Otezla 30mg tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This contract award, valued at $32,404.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The award provides for the delivery of Otezla 30 mg tablets under a firm-fixed-price delivery order contract. The contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $73,304.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat various conditions. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,549.75 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a medication, to support military healthcare programs. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...